M42 is shaping the sustainable future of global healthcare by positioning Abu Dhabi at the centre of health innovation and technological advancement. The Group’s strategy is built on using technology not merely as a support tool, but as a transformative force to co-create the future of health. By harnessing advanced capabilities in artificial intelligence, genomics, and data science, M42 is delivering precise, personalised, and preventive healthcare solutions at scale.
Operating at the intersection of healthcare and innovation, M42 continues to expand its global footprint while strengthening healthcare accessibility, quality, and resilience. Through strategic partnerships, groundbreaking clinical achievements, and large-scale population health initiatives, the Group is redefining how healthcare is delivered—locally, regionally, and globally.
Throughout 2024 and 2025, M42 achieved major milestones that underscore its commitment to sustainable global health. These include strategic collaborations with global leaders such as Oracle Health, GE HealthCare, AstraZeneca, Toshiba Energy Systems, and Microsoft; the expansion of precision medicine through genomics and AI-enabled diagnostics; and the launch of advanced healthcare platforms across the UAE, Saudi Arabia, Jordan, and beyond.
Notable achievements include the integration of pharmacogenomics into electronic health records, the launch of the Middle East’s first Precision Nutrition System, the expansion into Saudi Arabia aligned with Vision 2030, and the establishment of Jordan’s first Digital Health Centre. M42 has also led medical breakthroughs such as robotic cancer surgery, AI-powered tuberculosis screening at population scale, and the development of one of the world’s most comprehensive genomic databases.
By advancing inclusive care models, supporting People of Determination, empowering local talent, and enabling digital health ecosystems, M42 continues to demonstrate its commitment to equitable and patient-centred healthcare. With a strong focus on innovation, prevention, and long-term impact, M42 is helping shape a future where high-quality healthcare is accessible, sustainable, and driven by science and technology—extending from Abu Dhabi to the world.